Marek's Disease Virus Disables the ATR-Chk1 Pathway by Activating STAT3

Xue Lian1,2,3, Chenyi Bao1,2, Xueqi Li1,2

  • 1MOE Joint International Research Laboratory of Animal Health and Food Safety, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing, China.

Journal of Virology
|February 22, 2019
PubMed

Insights

Marek

Area of Science:

  • Virology
  • Molecular Biology
  • Cellular Biology

Background:

  • Oncogenic viruses can cause DNA damage, activating the DNA damage response (DDR) pathway, which is crucial for viral replication and tumorigenesis.
  • Marek's disease virus (MDV) induces DNA damage in infected cells, but its interaction with the host DDR pathway remains unclear.
  • Understanding how viruses manipulate the DDR pathway is key to developing antiviral strategies.

Purpose of the Study:

  • To investigate the interaction between Marek's disease virus (MDV) and the host DNA damage response (DDR) pathway.
  • To elucidate the mechanism by which MDV manipulates cellular signaling to promote its replication.
  • To identify specific pathways targeted by MDV during infection.

Main Methods:

  • Assessed DNA damage markers (p53, p21) and DNA strand breaks in MDV-infected chicken cells.
  • Measured phosphorylation of STAT3 and Chk1 in response to MDV infection.
  • Utilized ATR-specific inhibitor (VE-821) and activator (hydroxyurea) to study ATR pathway involvement.
  • Employed Stattic to inhibit STAT3 phosphorylation and assessed its impact on MDV replication and Chk1 phosphorylation.

Main Results:

  • MDV infection induced DNA strand breakage and increased p53 and p21 levels in chicken cells.
  • MDV infection led to increased STAT3 phosphorylation and decreased Chk1 phosphorylation.
  • MDV infection was enhanced by ATR inhibition and attenuated by ATR activation.
  • Inhibiting STAT3 phosphorylation with Stattic reduced MDV's ability to inhibit Chk1 and decreased viral replication.

Conclusions:

  • MDV infection activates STAT3, which in turn disables the ATR-Chk1 pathway, promoting viral replication.
  • This study reveals a novel mechanism of MDV evading host antiviral responses by manipulating the ATR-Chk1 pathway via STAT3.
  • Findings provide new insights into virus-host interactions and potential therapeutic targets for MDV-induced lymphoma.

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
8.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
2.4K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.3K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.2K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K